Search results

Neutron scattering instruments used by Japanese researchers.

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

Recent catastrophic Australian bushfires produced extremely high levels of fine particle pollution.

Research led by a group from the University of Newcastle has found a new way to make silcone surfaces – and have even discovered that they can control how slippery they are.

The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.

Thirty years of ANSTO's unique capability in monitoring fine particle pollution provides insight on bushfire smoke.

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.

Doping with transition metals produced stability in bismuth oxide.

Doping with transition metals produced stability in bismuth oxide.

Professor Vanessa Peterson, Senior Principal Research and Neutron Scattering Instrument Scientist and Leader of the Energy Materials Research project, has been awarded the Bob Cheary Award or Excellence in Diffraction Analysis by the Australian X-ray Analytical Association. She is the first female to be chosen for the award.

The NSW Government will invest $12.5 million to support the expansion of the Innovation Precinct at the Lucas Heights campus of the Australian Nuclear Science and Technology Organisation (ANSTO).

Data analysis on the X-ray fluorescence microscopy beamline at the Australian Synchrotron.

The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been appointed Chief Executive Officer of ANSTO following a global search for the position.